Eagle Health Investments »

Eli Lilly & Co. shares owned by Eagle Health Investments

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Eagle Health Investments from 13F filings

Historical chart of Eagle Health Investments investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Eagle Health Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Eagle Health Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.4M 2.0k 1199.43

More positions owned by Eagle Health Investments

Argenx Se Sponsored Adr (ARGX)
Icon Pub SHS (ICLR)
Guardant Health (GH)
Insmed Com Par $.01 (INSM)
BioMarin Pharmaceutical (BMRN)
Illumina (ILMN)
Scholar Rock Hldg Corp (SRRK)
Protagonist Therapeutics (PTGX)
Ultragenyx Pharmaceutical (RARE)
Compass Pathways Sponsored Ads (CMPS)
Ascendis Pharma A/s Ord Shs (ASND)
Revolution Medicines (RVMD)
Fortrea Hldgs Common Stock (FTRE)
Kymera Therapeutics (KYMR)
Axsome Therapeutics (AXSM)

View all positions for Eagle Health Investments

Top funds holding Eli Lilly & Co.

Lilly Endowment
BlackRock
Vanguard Capital Management
Pnc Financial Services
State Street Corporation
FMR
Capital Research Global Investors
Vanguard Portfolio Management
Geode Capital Management
Capital World Investors
Morgan Stanley
T. Rowe Price Associates
Jpmorgan Chase & Co
UBS Group
Norges Bank Investment Management

View all funds holding Eli Lilly & Co.